Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.18 USD | +0.60% | +0.39% | -23.07% |
Jun. 06 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call | |
May. 31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.07% | 5.68B | |
+48.15% | 57.87B | |
+41.65% | 40.25B | |
-6.85% | 39.94B | |
-5.96% | 28.54B | |
+12.98% | 26.4B | |
-20.42% | 19.33B | |
+31.30% | 12.4B | |
-0.13% | 12.23B | |
+24.74% | 12.2B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Ionis Pharmaceuticals Says Potential Angelman Syndrome Therapy Improves Symptoms in Phase 1/2a Study